Adiponectin attenuates the premature senescence of vascular smooth muscle cells induced by high glucose through mTOR signaling pathway
Open Access
- 29 April 2020
- journal article
- research article
- Published by Wiley in Aging Medicine
- Vol. 3 (3) , 178-187
Abstract
Objective: Cardiovascular diseases and vascular aging are common in patients with diabetes. High glucose is a major cause of vascular aging and cardiovascular diseases. Premature senescence of vascular smooth muscle cells (VSMCs) is one of the main contributors to vascular aging. Adiponectin has been demonstrated to have an anti‐aging effect. The present study explored the mechanisms by which adiponectin protects VSMCs against high‐glucose‐induced senescence.Methods: Senescence‐associated β‐galactosidase (SA‐β‐gal) staining was used to detect senescence cells. Western blot was used for measuring protein levels. Flow cytometry was carried out to detect the cell cycle and telomeric repeat amplification protocol (TRAP)–polymerase chain reaction (PCR) silver staining was selected to measure the telomerase activity.Results: Premature senescence of VSMCs was induced by high glucose (30 mM) in a time‐dependent manner, which was verified by an increased number of senescence cells, p21 and p53 expression, as well as the decreased proliferation index. High glucose reduced telomerase activity of VSMCs via inhibition of the AMPK/TSC2/mTOR/S6K1 pathway and activation of the PI3K/Akt/mTOR/S6K1 pathway, while adiponectin treatment significantly increased telomerase activity of VSMCs through activation of AMPK/TSC2/mTOR/S6K1 signaling and inhibition of PI3K/Akt/mTOR/S6K1 signaling.Conclusion: Adiponectin attenuated the high‐glucose‐induced premature senescence of VSMCs via increasing telomerase activity of VSMCs, which was achieved by activation of AMPK/TSC2/mTOR/S6K1 signaling and inhibition of PI3K/Akt/mTOR/S6K1 signaling.Keywords
Funding Information
- National Natural Science Foundation of China (81770833, 81974223)
This publication has 38 references indexed in Scilit:
- Advanced glycation end products accelerate calcification in VSMCs through HIF-1α/PDK4 activation and suppress glucose metabolismScientific Reports, 2018
- miR-34a Promotes Vascular Smooth Muscle Cell Calcification by Downregulating SIRT1 (Sirtuin 1) and Axl (AXL Receptor Tyrosine Kinase)Arteriosclerosis, Thrombosis, and Vascular Biology, 2018
- Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013JAMA, 2017
- Function, Role, and Clinical Application of MicroRNAs in Vascular AgingBioMed Research International, 2016
- Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAILVascular Pharmacology, 2016
- Prelamin A Accelerates Vascular Calcification Via Activation of the DNA Damage Response and Senescence-Associated Secretory Phenotype in Vascular Smooth Muscle CellsCirculation Research, 2013
- Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous MiceThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Mechanisms of Vascular Aging: New PerspectivesThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular diseaseDiabetologia, 2008